JM
James Mulay

James Mulay insider trades: CG Oncology (CGON) stock sales

CG Oncology Last trade Jul 10, 2026 13 Form 4 filings
$2.6M
Sold, last 12 months
4 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2025
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where James reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 10, 2026CGON↓ Sell$1.8M
Jun 15, 2026CGON↓ Sell$118K
Mar 16, 2026CGON↓ Sell$125K
Jan 9, 2026CGON↓ Sell$585K
Oct 9, 2025CGON↓ Sell$260K
Sep 29, 2025CGON↓ Sell$500K
Sep 19, 2025CGON↓ Sell$885K
Sep 5, 2025CGON↓ Sell$852K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CGON insiders

Open-market trades in the last 12 months

About James Mulay's insider trades

James Mulay is an insider at CG Oncology (CGON). Since Sep 5, 2025, James has reported no open-market purchases and 8 sales worth $5.1M on SEC Form 4. In the last 12 months: 4 sales ($2.6M).

Their filings also include option exercises (8 filings), grants and awards (5 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CGON insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.